Skip to content

GO-ONline: Individualized Internet-based Cognitive Behavioral Therapy for Suicidal Patients: An exploratory trial for proof of concept

GO-ONline: Individualized Internet-based Cognitive Behavioral Therapy for Suicidal Patients: An exploratory trial for proof of concept - GO-ONline

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027035
Enrollment
20
Registered
2021-11-02
Start date
2022-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

suicidal ideation R45

Interventions

Group 1: Blended care intervention based on cognitive behavioral therapy (12 sessions of videotherapy combined with individual online self-help modules). Before and after the blended care, (risk) asse

Sponsors

Medizinische Psychologie und Medizinische Soziologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) suicidal ideation (BSS > 2), (2) at least 18 years of age, (3) sufficient German language skills, (4) signed declaration of consent to participate in the study after extensive information about the study, (5) internet access at home, and (6) residence close enough to the respective outpatient clinic to allow for face-to-face treatment.

Exclusion criteria

Exclusion criteria: (1) acute psychotic states, (2) suicide intent in need of immediate inpatient treatment (ability to take distance from suicide intent and/or ability to give agreements not given), (3) intellectual disability and (4) additional psychotherapeutic treatment.

Design outcomes

Primary

MeasureTime frame
Feasibility. The following key domains of treatment feasibility are investigated: acceptability, demand, practicability, integration, first indications of efficacy, and safety. The domains will be investigated in a mixed-methods approach using the following assessments: Acceptability (STTS-R, NEQ, ZUF-THERA, self-created short assessment in online modules, qualitative interviews with therapists and patients), demand (number of attended sessions, termination against therapist recommendation, switching to face-to-face therapy, proportion of completed to assigned modules, qualitative interviews with therapists and patients), practicality (qualitative interviews with therapists and patients), adaptation (WAI-12, WAI-SR-T-12, qualitative interviews with therapists and patients), efficacy (BSS, SITBI-G interview), safety (serious adverse events checklist, therapists’ documentation of sessions, SITBI-G interview, short self-created assessment of perceived safety for patients and therapists, qualitative interviews with patients and therapists).

Secondary

MeasureTime frame
Depressiveness (PHQ-9), additional service use

Countries

Germany

Contacts

Public ContactLasse B. Sander

Medizinische Psychologie und Medizinische Soziologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg

lasse.sander@mps.uni-freiburg.de+49-761-203-5519

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026